Literature DB >> 16242476

Off-pump CABG with synchronized arterial flow ensuring system.

Go Watanabe1, Hiroyuki Kamiya, Hiroshi Nagamine, Shigeyuki Tomita, Yoshinao Koshida, Satoshi Nishida, Hiroshi Ohtake, Sadahiko Arai, Tamotsu Yasuda.   

Abstract

PURPOSE: We developed a synchronized, arterial-flow, ensuring system to perform coronary anastomoses safely without any ischemia-related event. DESCRIPTION: Arterial blood is removed from the femoral artery. The resulting blood passes a switching valve and is pumped out to a syringe pump. This pump controller provides pulsatile arterial blood flow synchronized with the diastolic phase on an electrocardiogram. The arterial blood is perfused to the coronary artery through a fine flexible cannula during anastomosis. EVALUATION: From February 1999, 524 consecutive patients were operated on using the synchronized arterial flow ensuring system. Mean duration for each anastomosis was 7.6 +/- 3.3 minutes (range, 4 to 20 min). There were no intraoperative fatal arrhythmias, ventricular arrhythmias, or short-run or hemodynamic deterioration during anastomoses. No hospital death was observed, and postoperative myocardial infarction occurred in 2 patients (0.4%). Postoperative angiography showed a 98.1% patency rate.
CONCLUSIONS: The early clinical and angiographical results for off-pump CABG with the synchronized arterial flow ensuring system were excellent without mortality. We believe that off-pump CABG can be more safely performed using the synchronized arterial flow ensuring system based on our favorable results.

Entities:  

Mesh:

Year:  2005        PMID: 16242476     DOI: 10.1016/j.athoracsur.2004.12.055

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  1 in total

1.  Beating-heart totally endoscopic coronary artery bypass grafting: report of a case.

Authors:  Satoru Nishida; Go Watanabe; Norihiko Ishikawa; Yujiro Kikuchi; Munehisa Takata; Teruaki Ushijima
Journal:  Surg Today       Date:  2009-12-29       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.